Results 71 to 80 of about 733 (138)

Hemotherapy with New Blood Products [PDF]

open access: yesTransfusion Medicine and Hemotherapy, 2018
Korte, Wolfgang, Zeerleder, Sacha S.
openaire   +3 more sources

PB2194: ISCHEMIC STROKE IN PATIENTS WITH THROMBOCYTOPENIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

open access: yesHemaSphere, 2022
M. Pérez Raya   +3 more
doaj   +1 more source

Myelomatous pleural effusion

open access: yeseJHaem, 2022
Silvia Escribano Serrat   +6 more
doaj   +1 more source

PB1900: COMBINED TREATMENT WITH VENETOCLAX PLUS HYPOMETHYLATING AGENT OR CYTARABINE VERSUS TREATMENT WITH HYPOMETHYLATING AGENT ALONE IN ACUTE MYELOID LEUKEMIA IN POOR PROGNOSIS PATIENTS.

open access: yesHemaSphere, 2023
Minerva Montalvo Saavedra   +11 more
doaj   +1 more source

PB2210: COMPARISON OF THREE PROGNOSTIC SCORING SYSTEMS FOR THE RISK OF THROMBOSIS IN ESSENTIAL THROMBOCYTHEMIA: ANALYSIS OF 190 PATIENTS AT THE UNIVERSITY HOSPITAL OF THE CANARY ISLANDS (1990-2022)

open access: yesHemaSphere, 2023
Jose Maria Raya   +11 more
doaj   +1 more source

A Manual of Hemotherapy [PDF]

open access: yesJournal of Clinical Pathology, 1987
openaire   +1 more source

P1335: SECONDARY MALIGNANCIES AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION. SINGLE HOSPITAL EXPERIENCE.

open access: yesHemaSphere, 2022
A. Dorado López   +7 more
doaj   +1 more source

[Hemotherapy in kidney transplantation].

open access: yesVojnosanitetski pregled, 2001
A total of 40 kidney transplantations (37 males and 3 females) from living donors (Group I) and 10 kidney transplantations (6 males and 4 females) from cadavers (Group II) were performed in the period 1996-October 1999 at the Military Medical Academy (MMA).
openaire   +1 more source

PB1977: EVALUATION OF ANTIBODY RESPONSES AMONG FIVE DIFFERENT SARS-COV-2 VACCINES IN CHRONIC MYELOID LEUKEMIA PATIENTS – A REAL-WORLD STUDY

open access: yesHemaSphere, 2023
Ana Carolina Toreli   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy